Christopher Fontenot, DO
Family Medicine · Lafayette, LANPI 1700204898
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.3% of the total across 49 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $395, more than ten times the $30 reported in 2019.
Across 49 payments — averaging $28.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$172
- GSK$144
- Organogenesis Inc.$125
- Pfizer$104
- Bayer$96
- Astellas Pharma US Inc$92
- plus $646 from 19 others
What the payments were for
- Food & beverage$1,28693%
- Education$927%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 1 | $172 |
| GSK | 3 | $144 |
| Organogenesis Inc. | 1 | $125 |
| Pfizer | 6 | $104 |
| Bayer | 5 | $96 |
| Astellas Pharma US Inc | 1 | $92 |
| Exact Sciences | 4 | $78 |
| AbbVie | 3 | $52 |
| Sun Pharmaceutical Industries Inc. | 2 | $51 |
| Johnson & Johnson | 2 | $48 |
| Novartis | 3 | $47 |
| Mimedx Group, Inc. | 3 | $42 |
| Phadia US Inc. | 2 | $37 |
| Organon | 2 | $31 |
| Axonics, Inc. | 1 | $31 |
| Lundbeck LLC | 1 | $28 |
| Boston Scientific | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Ultragenyx Pharmaceutical Inc. | 1 | $23 |
| Amgen | 1 | $23 |
| Dexcom, Inc. | 1 | $23 |
| KCI USA, Inc. | 1 | $23 |
| Global Blood Therapeutics, Inc. | 1 | $22 |
| Dynavax Technologies Corporation | 1 | $20 |
| Abbott | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,378 in reported general payments places this provider in the 60th percentile of 1,469 family medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amlodipine Besylate | 22 | $154 |
| Tamsulosin Hcl | 11 | $128 |
| Azathioprine | 11 | $105 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Lafayette
- Geoffrey MireLafayette$13K
- Darrin MenardLafayette$13K
- Christine SmithBaton Rouge$185K
- Thomas DansbyMonroe$169K
- Michael FlemingShreveport$165K
- Robert St AmantGonzales$156K
- William HathawaySpringhill$105K
- Cesar GonzalesWest Monroe$94K
- Phillip ConnerSulphur$71K
- Richard JeansonneMandeville$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.